| Groupa | P-value | ||
---|---|---|---|---|
I (n = 33) | II (n = 30) | III (n = 29) | ||
UICC stage III, n | 10 | 8 | 8 | Â |
UICC stage IV, n (%) | 23 (70) | 22 (73) | 21 (72) | Â |
Whole blood cell count, mean ± SD |  |  |  | |
 UICC stage III | -0.11 ± 0.54e | -0.04 ± 0.29c | -2.34 ± 0.74cde | <0.001b |
 UICC stage IV | -1.19 ± 0.73e | -0.03 ± 0.35c | -2.06 ± 0.75cde | <0.001b |
Lymphocyte levels | Â | Â | Â | Â |
 UICC stage III | -0.68 ± 0.34e | 0.21 ± 0.59c | -0.91 ± 0.41de | <0.001b |
 UICC stage IV | -0.77 ± 0.46e | 0.23 ± 0.54c | -1.02 ± 0.57de | <0.001b |
Neutrophil granulocytes, mean ± SD |  |  |  | |
 UICC stage III | -0.38 ± 0.63 | -0.33 ± 0.47 | -1.16 ± 0.56de | 0.015b |
UICC stage IV | -0.35 ± 0.50e | -0.36 ± 0.52e | -0.86 ± 0.63cde | 0.004b |
MID, mean ± SD |  |  |  | |
 UICC stage III | -0.15 ± 0.22 | 0.10 ± 0.24 | -0.29 ± 0.25de | 0.013b |
 UICC stage IV | -0.07 ± 0.23 | 0.05 ± 0.23 | -0.17 ± 0.18de | 0.005b |
Platelet counts, mean ± SD |  |  |  | |
 UICC stage III | -22.20 ± 70.85 | -23.00 ± 22.01e | -25.57 ± 27.09e | 0.990 |
 UICC stage IV | -54.09 ± 35.46e | -7.68 ± 19.49c | -23.91 ± 29.30cde | <0.001b |